ABC  Vol.4 No.5 , August 2014
Determination of Binding Parameters of Miramistin to Serum Albumin by the Bioluminescent Method
Abstract: Bioassay based on the luminescent bacteria was used as a new method for the determination of the kinetic constants of ligand binding to the complexion agent. Miramistin as the cationic surface-active antiseptic and serum blood albumin was taken as a model of interacting agent’s. It was concluded that this approach might have a wide range for applications, namely, in all cases where the ligand is an inhibitor of bacterial luminescence and its complex dose not effect the intensity of this process.
Cite this paper: Starodub, N. , Katsev, A. , Abduramanova, E. , Safronyuk, S. and Taran, M. (2014) Determination of Binding Parameters of Miramistin to Serum Albumin by the Bioluminescent Method. Advances in Biological Chemistry, 4, 331-338. doi: 10.4236/abc.2014.45038.

[1]   Pahikkala, T., Airola, A., Pietil, S., Shakyawar, S., Szwajda, A., Tang, J. and Aittokallio, T. (2014) Toward More Realistic Drug-Target Interaction Predictions. Briefings in Bioinformatics, April 9. (In Press).

[2]   Bourassa, P., Thomas, T.J. and Tajmir-Riahi, H.A. (2014) Locating the Binding Sites of Antitumor Drug Tamoxifen and Its Metabolites with DNA. Journal of Pharmaceutical and Biomedical Analysis, 95, 193-199.

[3]   Sykes, D.A., Parry, C., Reilly, J., Wright, P., Fairhurst, R.A. and Charlton, S.J. (2014) Observed Drug-Receptor Association Rates Are Governed by Membrane Affinity: The Importance of Establishing “Micro-Pharmacokinetic/Pharmaco-Dynamic Relationships” at the В2-Adrenoceptor. Molecular Pharmacology, 85, 608-617.

[4]   Lopez-Roldan, R., Kazlauskaite, L., Ribo, J., Riva, M.C., Gonzбlez, S. and Cortina, J.L. (2012) Evaluation of an Automated Luminescent Bacteria Assay for in Situ Aquatic Toxicity Determination. Science of the Total Environment, 440, 307-313.

[5]   Varfolomeev, S.D. and Zaitsev, S.V. (1982) Kinetic Methods in Biochemical Investigations. Moscow University, Moscow, 342 p.

[6]   Roda, A., Guardigli, M., Mishelini, E., et al. (2003) Analytical Bioluminescence and Chemiluminescence. Analytical and Bioanalytical Chemistry, 75, 462-470.

[7]   Parvez, S., Venkataraman, C. and Mukherji, S. (2006) A Review on Advantages of Implementing Luminescence Inhibition Test (Vibrio fischeri) for Acute Toxicity Prediction of Chemicals. Environment International, 32, 265-268.

[8]   Katsev, A.M. and VIu, S. (2002) Interaction of Cationic Surface-Active Antiseptics and Serum Albumin by the Bacterial Bioluminescence Method. Clinical Laboratory Diagnostics, 4, 39-41.

[9]   Luik, A.I. and Lukianchuk, V.D. (1984) Serum Albumin and Biotransport of Poison. Medicina, Moscow, 224 p.

[10]   Miller, Y.I. (1993) Binding of Xenobiotics by Serum Albumin. Clinical Laboratory Diagnostics, 1, 34-40.

[11]   Katsev, A.M., Onuchina, I.G., Gordienko, A.I. and Beloglazov, V.A. (2001) Bioluminescent Method for Lipopolysaccharide Determination. Tavrichesky Medico-Biological Bulletin, 4, 120-123.

[12]   Katsev, A.M. and Vlu, S. (2001) Method for Estimation of Binding capacity of Seralbumin. Tavrichesky Medico-biological Bulletin, 4, 147-150.

[13]   Katsev, A.M., Onuchina, I.G., Gordienko, A.I. and Beloglazov, V.A. (2002) Study of the Binding between Bacterial Lipopolysaccharides and Polymyxin by a Bioluminescent Method. Ukrainian Biochemical Zhurnal, 74, 103-107.